This came up months ago but has been more seriously followed up on. As Philip says on Furious Seasons it’s unclear if this is to be a “black box” warning yet, the most serious of warnings on pharmaceuticals. These are the “mood-stabilizers” that were first created as anti-convulsants.
“The risk of suicidal thoughts or behavior was generally consistent among the eleven drugs analyzed and was observed in patients who were treated for epilepsy, psychiatric disorders, and other conditions,” the Food and Drug Administration said in a statement on its website. (read article here)
If I recall correctly the first time this came up the correlation was said to be stronger among non-psychiatric users. Now it’s clear it doesn’t matter what condition is being treated.
And to quote Philip because I can’t say it better:
I think it’s pretty safe to say that, taken together, psychotropic medications have more warnings and black boxes on them than any other therapeutic group of drugs. Pretty staggering when you consider how widely they are used.
There is very little information available right now about exactly what the FDA is doing, but I think it’s important that what so many of us already know is being put on the labels of these drugs. I know I’ve had radical behavioral and emotional shifts triggered by all sorts of psychotropic drugs. I have no problem imagining, from my experience alone that there is not a psychotropic drug on the market that might not be able to trigger a radical and unexpected response in any given individual. It’s a game of russian roulette doing med trials and a lot of people want to play.
The drugs they’re talking about now are:
Epilepsy drugs include Pfizer Inc’s Lyrica and Neurontin, GlaxoSmithKline PLC’s Lamictal and Johnson & Johnson’s Topamax.
And I can say that Topamax made me wildly insane if not suicidal. And Lamictal caused the withdrawal from hell, which you can read about by following that link. It’s over now but I’m still suffering from the fatigue and malaise it caused.